BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10711132)

  • 1. A review of NSAID complications: gastrointestinal and more.
    Beehrle DM; Evans D
    Lippincotts Prim Care Pract; 1999; 3(3):305-15. PubMed ID: 10711132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs.
    Knodel LC; Roush MK; Barton TL
    Clin Podiatr Med Surg; 1992 Apr; 9(2):301-25. PubMed ID: 1586906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness and frequency of potential side effects on nonsteroidal anti-inflammatory drugs among the Jordanian patient population.
    Albsoul-Younes AM; Jabateh SK; Abdel-Hafiz SM; Al-Safi SA
    Saudi Med J; 2004 Jul; 25(7):907-11. PubMed ID: 15235698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract].
    Bures J; Rejchrt S; Kopácová M; Siroký M
    Cas Lek Cesk; 2002 Oct; 141(21):673-9. PubMed ID: 12564374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The lack of awareness of the Israeli population regarding gastrointestinal complications from non-steroidal anti-inflammatory drugs].
    Zandman-Goddard G; Langevitz P
    Harefuah; 2001 Jun; 140(6):476-8, 567, 566. PubMed ID: 11420844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAIDs-induced gastrointestinal damage. Review.
    Arroyo M; Lanas A
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):249-59. PubMed ID: 16971869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal antiinflammatory drugs. A review.
    Winzeler S; Rosenstein BD
    AAOHN J; 1998 May; 46(5):253-9; quiz 260-1. PubMed ID: 9652239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs.
    Harris CL; Raisch DW; Abhyankar U; Marfatia S; Campbell HM; Sather MR
    Ann Pharmacother; 2006 Nov; 40(11):1924-31. PubMed ID: 17047140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal adverse effects of nonsteroidal anti-inflammatory drugs.
    Harirforoosh S; Jamali F
    Expert Opin Drug Saf; 2009 Nov; 8(6):669-81. PubMed ID: 19832117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis.
    Schifferdecker B; Spodick DH
    Cardiol Rev; 2003; 11(4):211-7. PubMed ID: 12852799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
    Targownik LE; Metge CJ; Leung S; Chateau DG
    Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nonsteroidal-anti-inflammatory drugs and serious undesirable gastrointestinal effects].
    Fabijanić D; Kardum D; Banić M; Fabijanić A
    Lijec Vjesn; 2007; 129(6-7):205-13. PubMed ID: 18018712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
    Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
    Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB; Phillips BB
    Ann Pharmacother; 2004 Sep; 38(9):1469-81. PubMed ID: 15213313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A; Hunt R
    Ann Med; 2006; 38(6):415-28. PubMed ID: 17008305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs: indications for use.
    Middleton C
    Nurs Times; 2003 Apr 22-28; 99(16):30-2. PubMed ID: 12739281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.